Spots Global Cancer Trial Database for Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
Official Title: Clinical Evaluation of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems
Study ID: NCT03421626
Conditions
Interventions
Study Description
Brief Summary: The objective of this study is to establish the performance of an assay that detects mRNA transcript levels in patients diagnosed with CML. The study is conducted at locations within the United States. Testing is performed on peripheral blood specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Broward Oncology Associates, Fort Lauderdale, Florida, United States
St. Alphonsus Regional Medical Center, Boise, Idaho, United States
WJB Dorn VA Medical Center, Columbia, South Carolina, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
United Hospital Center, Bridgeport, West Virginia, United States
St. Mary's Medical Center, Huntington, West Virginia, United States
Marshfield Clinic, Marshfield, Wisconsin, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
